Neuberger, E. E., Abbass, I. M., Jones, E., & Engmann, N. J. (2020). Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis. Neurol Ther.
Citação norma ChicagoNeuberger, Edward E., Ibrahim M. Abbass, Eddie Jones, and Natalie J. Engmann. "Work Productivity Outcomes Associated With Ocrelizumab Compared With Other Disease-Modifying Therapies for Multiple Sclerosis." Neurol Ther 2020.
MLA citiranjeNeuberger, Edward E., Ibrahim M. Abbass, Eddie Jones, and Natalie J. Engmann. "Work Productivity Outcomes Associated With Ocrelizumab Compared With Other Disease-Modifying Therapies for Multiple Sclerosis." Neurol Ther 2020.
Opozorilo: Ti citati niso vedno 100% točni.